-
公开(公告)号：US11465980B2
公开(公告)日：2022-10-11
申请号：US16286700
申请日：2019-02-27
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C. K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： C07D401/12 , A61K31/445 , C07D403/12 , C07D401/14 , C07D405/14 , C07D241/04 , C07D451/02 , C07D211/22
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
公开(公告)号：US10246436B2
公开(公告)日：2019-04-02
申请号：US15252112
申请日：2016-08-30
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C. K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： A61K31/445 , C07D211/22 , C07D401/12 , C07D401/14 , C07D241/04 , C07D403/12 , C07D405/14 , C07D451/02
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
3.发明申请公开(公告)号：US20190202803A1
公开(公告)日：2019-07-04
申请号：US16286700
申请日：2019-02-27
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C.K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： C07D401/12 , C07D405/14 , C07D403/12 , C07D451/02 , A61K31/445 , C07D241/04 , C07D211/22 , C07D401/14
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
4.发明公开公开(公告)号：US20230203002A1
公开(公告)日：2023-06-29
申请号：US17879923
申请日：2022-08-03
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C.K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： C07D401/12 , A61K31/445 , C07D403/12 , C07D401/14 , C07D405/14 , C07D241/04 , C07D451/02 , C07D211/22
CPC分类号： C07D401/12 , A61K31/445 , C07D403/12 , C07D401/14 , C07D405/14 , C07D241/04 , C07D451/02 , C07D211/22
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
5.发明申请公开(公告)号：US20200231564A9
公开(公告)日：2020-07-23
申请号：US16286700
申请日：2019-02-27
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C.K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： C07D401/12 , C07D405/14 , C07D403/12 , C07D451/02 , A61K31/445 , C07D241/04 , C07D211/22 , C07D401/14
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
6.发明申请公开(公告)号：US20170210725A1
公开(公告)日：2017-07-27
申请号：US15252112
申请日：2016-08-30
申请人： Trevena, Inc.
发明人： Aimee Crombie Speerschneider , Dennis Shinji Yamashita , Philip Michael Pitis , Michael John Hawkins , Guodong Liu , Tamara Ann Miskowski Daubert , Catherine C.K. Yuan , Robert Borbo Kargbo , Robert Jason Herr , Donna Romero , Gregory J. Pacofsky
IPC分类号： C07D401/12 , C07D451/02 , C07D405/14 , C07D401/14 , C07D211/22
CPC分类号： C07D401/12 , A61K31/445 , C07D211/22 , C07D241/04 , C07D401/14 , C07D403/12 , C07D405/14 , C07D451/02 , A61K2300/00
摘要： The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.016 秒)
